Metastatic Breast Cancer
Conditions
Keywords
metastatic breast cancer
Brief summary
Enrollment in clinical trials usually favors a particular demographic group. But there is limited research available to explain what study attributes affect the completion of these specific demographic groups. This trial will evaluate the safety and efficacy of metastatic breast cancer treatments. The focus will be on tracking the rates of completion and withdrawal among these individuals. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future metastatic breast cancer studies.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient is at least 18 years of age * Patient is able and willing to comply with the treatment/follow-up schedule and requirements * Patient must provide written informed consent
Exclusion criteria
* Women who are pregnant, intend to become pregnant, or are lactating * Inability to perform regular electronic reporting * Participants who are vulnerable to any intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients who decide to enroll in a metastatic breast cancer clinical study. | 3 months |
| Number of metastatic breast cancer study participants who remain in clinical trial until completion. | 12 months |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed